2016 American Transplant Congress » Poster Session D: Kidney-Pediatrics
Date: Tuesday, June 14, 2016
Time: 6:00pm-7:00pm
Location: Halls C&D
Session Type: Poster Session
Meeting: 2016 American Transplant Congress
- 6:00pm-7:00pm
Alemtuzumab Is Safe and Effective Induction Therapy in Highly Sensitized (HS) Pediatric Patients Undergoing Transplantation.
- 6:00pm-7:00pm
Donor-Specific Antibodies in a Single-Center Pediatric Kidney Transplant Population – Incidence and Risk Factors.
- 6:00pm-7:00pm
Factors Predicting Risk for Antibody-Mediated Rejection in Highly Sensitized Pediatric Renal Transplants.
- 6:00pm-7:00pm
Geographic Variability in Access to Transplant Centers for Children with End-Stage Renal Disease.
- 6:00pm-7:00pm
Impact of Everolimus and Low-Dose Ciclosporin on Cytomegalovirus Replication and Disease in Pediatric Renal Transplantation.
- 6:00pm-7:00pm
Incidence of Post-Transplant Cardiovascular Disease After Pediatric Kidney Transplantation.
- 6:00pm-7:00pm
Incidence of Post-Transplant Malignancy (PTM) After Pediatric Kidney Transplantation (PKTx).
- 6:00pm-7:00pm
Pediatric Kidney Transplantation and Mortality: Distance to Transplant Center Matters.
- 6:00pm-7:00pm
Renal Outcomes of Pediatric Kidney Transplant Recipients Following a Previous Solid Organ Transplantation.
- 6:00pm-7:00pm
The Effect of Bortezomib on DSA Reduction During the Treatment of AMR in Pediatric Kidney Transplant Patients.
« View all sessions from the 2016 American Transplant Congress